InterCure Ltd. (TASE:INCR) entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd on January 19, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,191 ILa | -4.11% | +5.31% | +157.18% |
May. 01 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
May. 01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+157.18% | 154M | |
-.--% | 339M | |
+52.26% | 299M | |
+35.05% | 279M | |
+45.65% | 132M | |
-41.95% | 119M | |
-28.57% | 122M | |
+34.62% | 118M | |
+100.00% | 60.26M | |
+8.62% | 56.81M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd.